Ottawa, June 21, 2022 (GLOBE NEWSWIRE) -- The global vascular grafts market size was valued at USD 5.37 billion in 2021. The vascular graft market shows a tremendous growth owing to the increase in the number of minimally invasive procedures carried out by the technically advanced hospitals and healthcare systems. This minimally invasive procedure has become a major part of many surgical procedures related to the vital organs in the human body.
Get the Sample Pages of Report@ https://www.precedenceresearch.com/sample/1758
Regional Snapshots
The region of North America is considered to be the largest ground for the development of this market. Owing to the rising health care awareness, availability of facilities, high number of people living in this developed country, high availability of reimbursement and the shift to advanced procedures are helping the market to grow. However, the region of Asia Pacific has also shown a tremendous growth during the forecast. This region is seen to have a high number of patients suffering with cardiovascular diseases, kidney problems and diabetes which helped to fuel this market to a great extent. The other regions which help in the growth of this market are Europe and Russia which also have a great number of cases with cardiovascular diseases and renal disorders.
Report Highlights
- On the basis of the product, the endovascular stent grafts segment is expected to dominate the market in the forecast period. The developments in the endovascular applications will lead to a growth in the endovascular stent grafts market.
- The cardiac aneurysm segment will grow during the forecast period as the congenital heart disease and other congenital heart surgeries which are carried out using the advanced tissue engineered grafts is in demand and the demand shall grow.
- On the basis of the raw material used, the polytetrafluoroethylene segment is expected to grow during the forecast period, it is used for the peripheral bypass procedures as this material adequately interacts with the tissue and it is extremely easy to use.
Scope of the Report
Report Attributes | Details |
Market Size in 2021 | USD 9.68 Billion |
Revenue Forecast by 2030 | USD 43.1 Billion |
CAGR | 18.05% from 2022 to 2030 |
Base Year | 2021 |
Forecast Year | 2022 to 2030 |
Key Players | Strem Chemicals, Inc., American Elements, US Research Nanomaterials, Inc., Nanocomposix, Inc., Frontier Carbon Corporation, Nanoshel LLC, SkySpring Nanomaterials, Inc., Nanophase Technologies Corporation, Cytodiagnostics, Inc., Quantum Materials Corp |
Ask here for more customization study@ https://www.precedenceresearch.com/customization/1758
Market Dynamics
Drivers
The factors driving this market includes the high number of chronic kidney diseases amongst the people, the increase in the number of dialysis that take place, the high rate of diabetic individuals. Moreover, the existence of cardiovascular diseases and renal disorders has helped to grow the market to a great extent. The adoption of minimally invasive procedures carried out by the advanced healthcare system has also increased the demand for vascular graft market over the period of time. This also helps in better healing of wounds and further reduces the complications that the patient has to undergo. The reduction in neointimal formation followed after complex vascular surgeries have shown a tremendous growth in the market during the forecast.
Restraints
The outbreak of the pandemic led to a decline in the market growth of the vascular grafts due to the interruption in the operation procedures and supply chains. As a result of the pandemic only essential services were carried out and non essential surgeries and procedures were neglected. Elective procedures had become the fashion of the ongoing market. During the pandemic the vascular and cardiac operative procedures witnessed a 8.5% decrease worldwide. Moreover, the increase in the total cost of the vascular graft procedures also hinders the growth of the market during the forecast. The developed nations opt for these services whereas the developing and underdeveloped nations face a challenge to cope with the increasing cost.
Opportunities
The increase in the minimally invasive procedures which are required for chronic heart diseases and renal diseases has provided a great opportunity for the growth of the vascular graft market. The reduced side effects and complications faced by the patients has helped the market to grow. The peripheral vascular market is another segment which shows tremendous growth due to the increased number of renal disorder and arterial diseases. All these factors provide a great opportunity to the vascular graft market during the forecast.
Challenges
The failure of a vascular graft can have severe adverse effects on the health of consumers. Malfunction of vascular grafts can cause a risk to the life of the consumer and hence the adoption of the new advanced technology will be hampered to a great extent which can affect the growth of the market in the forecast period. The higher cost associated with these kind of graphs also creates a great challenge for the developing market. Failure of a vascular graft also leads to an additional expense in which an operation has to be done again. All these factors proved to be a great challenge for the growth of the vascular graft market.
- Browse more Healthcare Industry Research Reports@ https://www.precedenceresearch.com/vascular-grafts-market
Get Our Latest Press Releases@ https://www.precedenceresearch.com/press-releases
Recent Developments
- Medtronic has obtained approval for ll/lls, Thoracic stent which is used along with Heli-FX EndoAnchor.
- In 2017, Endologix Inc has made an agreement with Deerfield management which is a healthcare organization. A funding worth $170 million has been granted to it.
Market Segmentation
By Product
- Vascular Grafts for Aorta Disease
- Peripheral Vascular Grafts
- Endovascular Stent Grafts
- Coronary Artery By-Pass Grafts
By Application
- Cardiac Aneurysm
- Kidney Failure
- Vascular Occlusion
- Coronary Artery Disease
By Raw Material
- Polyester Vascular Grafts
- Polytetrafluoroethylene Vascular Grafts
- Polyurethane Vascular Grafts
- Biological Material Based Vascular Grafts
- Human Saphenous and Umbilical Veins
- Tissue Engineered Materials
By End User
- Hospitals
- Ambulatory Surgical Centers
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Immediate Delivery Available | Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1758
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333
About Us
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
For Latest Update Follow Us:
https://www.linkedin.com/company/precedence-research/
https://www.facebook.com/precedenceresearch/
https://twitter.com/Precedence_R